HOXC13 and cervical cancer: Additionally, FTO reduced m6A and stabilized HOXC13-AS thus up-regulating FZD6 and activating Wnt/β-catenin signaling to drive cervical cancer cell proliferation, invasion and epithelial mesenchymal transition, suggesting HOXC13-AS as a potential target for cervical cancer treatment [46].